234 related articles for article (PubMed ID: 8152797)
41. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
Yu D; Shi D; Scanlon M; Hung MC
Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic consequences of down-modulating TIMP expression in 3T3 cells with antisense RNA.
Denhardt DT; Khokha R; Yagel S; Overall CM; Parhar RS
Matrix Suppl; 1992; 1():281-5. PubMed ID: 1480038
[TBL] [Abstract][Full Text] [Related]
43. Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts.
Cavari S; Ruggiero M; Vannucchi S
Cell Biol Int; 1993 Aug; 17(8):781-6. PubMed ID: 8106075
[TBL] [Abstract][Full Text] [Related]
44. Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic.
Hromas R; Morris J; Cornetta K; Berebitsky D; Davidson A; Sha M; Sledge G; Rauscher F
Cancer Res; 1995 Aug; 55(16):3610-4. PubMed ID: 7627970
[TBL] [Abstract][Full Text] [Related]
45. Mutant alpha subunit of Gz transforms Swiss 3T3 cells.
Wong YH; Chan JS; Yung LY; Bourne HR
Oncogene; 1995 May; 10(10):1927-33. PubMed ID: 7761094
[TBL] [Abstract][Full Text] [Related]
46. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells.
Kieser A; Seitz T; Adler HS; Coffer P; Kremmer E; Crespo P; Gutkind JS; Henderson DW; Mushinski JF; Kolch W; Mischak H
Genes Dev; 1996 Jun; 10(12):1455-66. PubMed ID: 8666230
[TBL] [Abstract][Full Text] [Related]
47. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
48. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
Carpenter PM; Mercola M; Mercola D
Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
[TBL] [Abstract][Full Text] [Related]
49. Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences.
Daniel R; Cai Y; Wong PM; Chung SW
Oncogene; 1995 Apr; 10(8):1607-14. PubMed ID: 7731715
[TBL] [Abstract][Full Text] [Related]
50. Identification and characterisation of the egr-1 gene product as an inducible, short-lived, nuclear phosphoprotein.
Waters CM; Hancock DC; Evan GI
Oncogene; 1990 May; 5(5):669-74. PubMed ID: 2189103
[TBL] [Abstract][Full Text] [Related]
51. Variation in agar growth of transformed 3T3 cells after tumor formation in nude mice.
Romerdahl CA; Rubin H
J Natl Cancer Inst; 1985 Jun; 74(6):1247-53. PubMed ID: 3889458
[TBL] [Abstract][Full Text] [Related]
52. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1.
Liu C; Adamson E; Mercola D
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11831-6. PubMed ID: 8876223
[TBL] [Abstract][Full Text] [Related]
53. Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis.
Gottschalk AR; Joseph LJ; Quintáns J
Eur J Immunol; 1993 Aug; 23(8):2011-5. PubMed ID: 8344366
[TBL] [Abstract][Full Text] [Related]
54. Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice.
Baron V; Duss S; Rhim J; Mercola D
Ann N Y Acad Sci; 2003 Dec; 1002():197-216. PubMed ID: 14751836
[TBL] [Abstract][Full Text] [Related]
55. KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1.
Gebelein B; Fernandez-Zapico M; Imoto M; Urrutia R
J Clin Invest; 1998 Dec; 102(11):1911-9. PubMed ID: 9835615
[TBL] [Abstract][Full Text] [Related]
56. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells.
Krishnaraju K; Hoffman B; Liebermann DA
Blood; 1998 Sep; 92(6):1957-66. PubMed ID: 9731053
[TBL] [Abstract][Full Text] [Related]
57. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
Yang D; Li T; Xu W
Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):26-8. PubMed ID: 7774440
[TBL] [Abstract][Full Text] [Related]
58. The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest.
Sells SF; Muthukumar S; Sukhatme VP; Crist SA; Rangnekar VM
Mol Cell Biol; 1995 Feb; 15(2):682-92. PubMed ID: 7823937
[TBL] [Abstract][Full Text] [Related]
59. Functional activation of the egr-1 (early growth response-1) gene by hydrogen peroxide.
Nose K; Ohba M
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):381-3. PubMed ID: 8687376
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism.
Huang RP; Adamson ED
DNA Cell Biol; 1993 Apr; 12(3):265-73. PubMed ID: 8466649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
